Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-05

Clinical Trial Update: A Study of Intravenous Perampanel in Japanese Participants With Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 intravenous perampanel study in Japanese participants with epilepsy has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perampanel (perampanel)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Epilepsy, Seizures | Phase 2 | Status: COMPLETED | Results posted: 2021-01-05